Roche in $550 mln deal for superbug-fighting antibiotic

Swiss drugmaker Roche will pay up to 500 million Swiss francs for an experimental antibiotic, marking a rare foray by a major pharmaceutical firm into the battle against so-called "superbug" infections found in hospitals.

http://www.trust.org/item/20131104084405-k44ak/?source=hpbreaking